Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shelia D Thomas

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
BMC Cancer|April 24, 2010
Hypoxia induces differential translation of enolase/MBP-1Kara C Sedoris, Shelia D Thomas, Donald M Miller
Biochemistry|June 28, 2007
c-myc promoter binding protein regulates the cellular response to an altered glucose concentrationKara C Sedoris, Shelia D Thomas, Donald M Miller
Archives of Toxicology|January 14, 2026
Arsenic disrupts autophagosome-lysosome fusion in a zinc dependent manner across multiple human skin and lung cells linesRachel V Goff, Sidimohamed Elmoustapha, Shelia D Thomas, et al.
Cancer Investigation|November 7, 2018
Nucleolin Overexpression Confers Increased Sensitivity to the Anti-Nucleolin Aptamer, AS1411Vivek R Sharma, Shelia D Thomas, Donald M Miller, et al.
Plos One|August 24, 2016
Discovery of a Family of Genomic Sequences Which Interact Specifically with the c-MYC Promoter to Regulate c-MYC ExpressionFrancine Rezzoug, Shelia D Thomas, Eric C Rouchka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2012
c-Myc and cancer metabolismDonald M Miller, Shelia D Thomas, Ashraful Islam, et al.
Nucleic Acids Research|May 30, 2002
Acridine-modified, clamp-forming antisense oligonucleotides synergize with cisplatin to inhibit c-Myc expression and B16-F0 tumor progressionDelisha A Stewart, Xiaohua Xu, Shelia D Thomas, et al.
The Journal of Biological Chemistry|January 28, 2014
c-Myc quadruplex-forming sequence Pu-27 induces extensive damage in both telomeric and nontelomeric regions of DNAMd Ashraful Islam, Shelia D Thomas, Vundavalli V Murty, et al.
Experimental and Molecular Pathology|May 21, 2009
Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancerPaula J Bates, Damian A Laber, Donald M Miller, et al.
Biochemistry|March 13, 2002
Antiproliferative activity of G-quartet-forming oligonucleotides with backbone and sugar modificationsVirna Dapić, Paula J Bates, John O Trent, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
BMC Cancer|April 24, 2010
Hypoxia induces differential translation of enolase/MBP-1Kara C Sedoris, Shelia D Thomas, Donald M Miller
Biochemistry|June 28, 2007
c-myc promoter binding protein regulates the cellular response to an altered glucose concentrationKara C Sedoris, Shelia D Thomas, Donald M Miller
Archives of Toxicology|January 14, 2026
Arsenic disrupts autophagosome-lysosome fusion in a zinc dependent manner across multiple human skin and lung cells linesRachel V Goff, Sidimohamed Elmoustapha, Shelia D Thomas, et al.
Cancer Investigation|November 7, 2018
Nucleolin Overexpression Confers Increased Sensitivity to the Anti-Nucleolin Aptamer, AS1411Vivek R Sharma, Shelia D Thomas, Donald M Miller, et al.
Plos One|August 24, 2016
Discovery of a Family of Genomic Sequences Which Interact Specifically with the c-MYC Promoter to Regulate c-MYC ExpressionFrancine Rezzoug, Shelia D Thomas, Eric C Rouchka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2012
c-Myc and cancer metabolismDonald M Miller, Shelia D Thomas, Ashraful Islam, et al.
Nucleic Acids Research|May 30, 2002
Acridine-modified, clamp-forming antisense oligonucleotides synergize with cisplatin to inhibit c-Myc expression and B16-F0 tumor progressionDelisha A Stewart, Xiaohua Xu, Shelia D Thomas, et al.
The Journal of Biological Chemistry|January 28, 2014
c-Myc quadruplex-forming sequence Pu-27 induces extensive damage in both telomeric and nontelomeric regions of DNAMd Ashraful Islam, Shelia D Thomas, Vundavalli V Murty, et al.
Experimental and Molecular Pathology|May 21, 2009
Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancerPaula J Bates, Damian A Laber, Donald M Miller, et al.
Biochemistry|March 13, 2002
Antiproliferative activity of G-quartet-forming oligonucleotides with backbone and sugar modificationsVirna Dapić, Paula J Bates, John O Trent, et al.
Pageof 2